Rocket Doctor AI Inc. enages in the development, deployment, and commercialization of the AI-powered healthcare platform and related products. It offers Global Library of Medicine (GLM) algorithms, ClinBot, AI Nurse, and Voice AI; digital health platform and physician marketplace; clinical training and assessment platform for medical, nursing, and other healthcare education programs; and knowledge platform that delivers real-time clinical intelligence. The company was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company is based in Vancouver, Canada.…
Rocket Doctor and a Leading Canadian Pharmacy Chain Launch Digital Healthcare Pilot Across 25 Canadian Pharmacy Locations
Rocket Doctor AI (CNSX: AIDR) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.3400 CAD on 20 November 2026, down 57.0% over 52 weeks. Its 52-week range is 0.3100 CAD to 0.8900 CAD: the price is 61.8% below the high and 9.7% above the low.
Its market capitalisation is 34.53M CAD.
Rocket Doctor AI reports return on equity of -446.7%.
It holds more cash than debt, a net cash position of 1.74M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 1.260 CAD is 270.6% above the current price.
No upcoming events tracked.